Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
529 S Jackson St
Louisville, KY 40202Phone+1 502-562-4370Fax+1 502-562-4373
Education & Training
- University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1998 - 2001
- University of Louisville School of MedicineResidency, Internal Medicine, 1995 - 1998
- B.J. Medical College - University of PuneClass of 1993
Certifications & Licensure
- IN State Medical License 1997 - 2025
- KY State Medical License 1998 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer. Start of enrollment: 2009 Mar 01
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2012 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 66 citationsEffect of omeprazole on oral iron replacement in patients with iron deficiency anemia.Vivek R. Sharma, Mark A. Brannon, Elizabeth A. Carloss
Southern Medical Journal. 2004-09-01 - 59 citationsIrinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results ...Robert C.G. Martin, Charles R. Scoggins, Dana Tomalty, Marshall T. Schreeder, Tiffany Metzger
Journal of Gastrointestinal Surgery. 2012-04-24 - 100 citationsRandomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.Robert C.G. Martin, Charles R. Scoggins, Marshall T. Schreeder, William S. Rilling, Christopher J. Laing
Cancer. 2015-10-15
Press Mentions
- Inaugural KentuckyOne Health Walk Gives People One-on-One Time with PhysiciansMarch 12th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: